NASDAQ NMS - GLOBAL MARKET · PRPO
+2.17% · +$0.5100 · Vol 62.8K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Precipio Inc

Precipio Inc

Health Care
$23.97
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
PRPO
Precipio Inc
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PRPO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PRPO catalysts
About Precipio Inc
LABORATORY ANALYTICAL INSTRUMENTS
Listed since
2000
Employees
71
Country
US

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$23.49
Day high
$25.04
Day low
$23.34
Previous close
$23.46
52W high
$32.37
-25.95% from high
52W low
$13.80
55% of range
Market cap
$42.8M
EPS
$-1.8700
Beta
0.55
Shares out
1.8M
Volume
62.8K
0.72× rel vol
Avg volume
87.6K
VWAP
$24.22
Price history computed in-house
1W
+10.72%
1M
-9.48%
3M
-19.59%
1Y
+72.45%
YTD
+4.31%
SMA 50 $23.42 · above
SMA 200 $24.48 · below
52W position 55%

PRPO overview

Veridion Score
59
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PRPO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PRPO Form 4 filings
Public disclosures

Congress activity in PRPO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PRPO in the cached public ledger.

Federal contracts

PRPO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PRPO in this window.
Lobbying spend

PRPO lobbying filings, year to date.

Registered lobbying filings matched to Precipio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PRPO in this window.
Loading news for PRPO
Analyst ratings
Sovereign unlock shows live analyst consensus for PRPO.
Options
Sovereign unlock shows live options positioning for PRPO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.